. Author manuscript; available in PMC: 2019 Apr 1.

Published in final edited form as: Vasc Med. 2018 Jan 18;23(2):97–106. doi: 10.1177/1358863X17745371

Table 1.

ABI Screening Recommendations from Societal Guidelines

Society	Recommendation	Year	Ref
US Preventive Services Task Force	Insufficient evidence that screening for PAD leads to clinically important benefits. Risk reduction interventions are recommended for high-risk individuals with known CVD or diabetes.	2013	¹⁰
American College of Cardiology / American Heart Association	In patients at increased risk of PAD but without history or physical examination findings suggestive of PAD, measurement of the resting ABI is reasonable. (Class IIa)	2016/17	¹¹
American College of Preventive Medicine	No routine screening is recommended; clinicians should be alert to symptoms of PAD in patients with risk factors (age≥50, smoking history, diabetes)	2011	¹²
American Diabetes Association	Screen patients with diabetes (symptomatic or asymptomatic and > 50 years old or have at least one other risk factor (smoking, hypertension, hyperlipidemia, diabetes > 10 years)	2015	¹³
European Society of Cardiology	Consider screening in patients with coronary artery disease	2011	¹⁴
Society of Vascular Surgery	Screening reasonable if used to improve risk stratification, preventive care, and medical management in asymptomatic patients at increased risk (adults > 70, smokers, diabetes, abdominal pulse examination or cardiovascular disease)	2015	¹⁵